{"id":"https://openalex.org/W180191204","doi":"https://doi.org/10.1096/fasebj.24.1_supplement.1030.13","title":"The Complement Split Products C3a and C5a are potent Activators of Mesenchymal Stem Cells","display_name":"The Complement Split Products C3a and C5a are potent Activators of Mesenchymal Stem Cells","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W180191204","doi":"https://doi.org/10.1096/fasebj.24.1_supplement.1030.13","mag":"180191204"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.24.1_supplement.1030.13","doi":"https://doi.org/10.1096/fasebj.24.1_supplement.1030.13","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.24.1_supplement.1030.13","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062097565","display_name":"Ingrid U. Schraufst\u00e4tter","orcid":"https://orcid.org/0000-0003-2084-9063","observed_orcids":["https://orcid.org/0000-0003-2084-9063"]},"institutions":[{"id":"https://openalex.org/I40399489","display_name":"Torrey Pines Institute For Molecular Studies","ror":"https://ror.org/01grq2104","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I40399489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ingrid Schraufstatter","raw_affiliation_strings":["Torrey Pines Institute for Molecular Studies San Diego CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Torrey Pines Institute for Molecular Studies San Diego CA","institution_ids":["https://openalex.org/I40399489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110966862","display_name":"Richard G. DiScipio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40399489","display_name":"Torrey Pines Institute For Molecular Studies","ror":"https://ror.org/01grq2104","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I40399489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Discipio","raw_affiliation_strings":["Torrey Pines Institute for Molecular Studies San Diego CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Torrey Pines Institute for Molecular Studies San Diego CA","institution_ids":["https://openalex.org/I40399489"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005894734","display_name":"Sophia K. Khaldoyanidi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40399489","display_name":"Torrey Pines Institute For Molecular Studies","ror":"https://ror.org/01grq2104","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I40399489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sophia Khaldoyanidi","raw_affiliation_strings":["Torrey Pines Institute for Molecular Studies San Diego CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Torrey Pines Institute for Molecular Studies San Diego CA","institution_ids":["https://openalex.org/I40399489"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I40399489"],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.01437797,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.7476000189781189,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.7476000189781189,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10176","display_name":"Mesenchymal stem cell research","score":0.24690000712871552,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mesenchymal-stem-cells","display_name":"mesenchymal stem cells","score":0.9120000004768372},{"id":"https://openalex.org/keywords/complement-split-products","display_name":"complement split products","score":0.8489999771118164},{"id":"https://openalex.org/keywords/c3a","display_name":"C3a","score":0.9810000061988831},{"id":"https://openalex.org/keywords/c5a","display_name":"C5a","score":0.9990000128746033},{"id":"https://openalex.org/keywords/c3a-receptor","display_name":"C3a receptor","score":0.8769999742507935},{"id":"https://openalex.org/keywords/c5a-receptor","display_name":"C5a receptor","score":1.0},{"id":"https://openalex.org/keywords/anaphylatoxin-receptors","display_name":"anaphylatoxin receptors","score":0.8360000252723694},{"id":"https://openalex.org/keywords/chemotaxis","display_name":"chemotaxis","score":0.8299999833106995},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.9449999928474426},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.9890000224113464},{"id":"https://openalex.org/keywords/angiogenic-factors","display_name":"angiogenic factors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9769999980926514},{"id":"https://openalex.org/keywords/basic-fibroblast-growth-factor","display_name":"basic fibroblast growth factor","score":0.9800000190734863},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.984000027179718},{"id":"https://openalex.org/keywords/tissue-damage","display_name":"tissue damage","score":0.6439999938011169},{"id":"https://openalex.org/keywords/bone-marrow-derived-stem-cells","display_name":"bone marrow-derived stem cells","score":0.765999972820282}],"concepts":[{"id":"https://openalex.org/C90582226","wikidata":"https://www.wikidata.org/wiki/Q424292","display_name":"Anaphylatoxin","level":4,"score":0.820507287979126},{"id":"https://openalex.org/C198826908","wikidata":"https://www.wikidata.org/wiki/Q1922379","display_name":"Mesenchymal stem cell","level":2,"score":0.8204431533813477},{"id":"https://openalex.org/C2779499704","wikidata":"https://www.wikidata.org/wiki/Q5008266","display_name":"C5a receptor","level":4,"score":0.724534273147583},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.6868387460708618},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.49653512239456177},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.48301801085472107},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47654539346694946},{"id":"https://openalex.org/C54166955","wikidata":"https://www.wikidata.org/wiki/Q658145","display_name":"Chemotaxis","level":3,"score":0.4739137887954712},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.447503924369812},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.43191128969192505},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35847151279449463},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3493350148200989},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.13147681951522827},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09173482656478882}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.24.1_supplement.1030.13","doi":"https://doi.org/10.1096/fasebj.24.1_supplement.1030.13","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.24.1_supplement.1030.13","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2116918434","https://openalex.org/W2286306316","https://openalex.org/W2574686074","https://openalex.org/W1984907210","https://openalex.org/W2969850739","https://openalex.org/W4308927181","https://openalex.org/W2585251126","https://openalex.org/W2010526570","https://openalex.org/W1486872989","https://openalex.org/W2123815050"],"abstract_inverted_index":{"It":[0,20],"is":[1,21,26,31,121],"known":[2,23,100],"that":[3,24,52,93,195,235,250],"mesenchymal":[4],"stem":[5],"cells":[6],"(MSC)":[7],"are":[8],"recruited":[9],"to":[10,15,119,144,168,184,210,244],"sites":[11],"of":[12,39,72,113,156,177,207,214,221,247,252,278],"tissue":[13,32],"injury":[14],"fulfill":[16],"their":[17,262],"repair":[18,264],"function.":[19],"also":[22],"there":[25,30],"complement":[27,41],"activation,":[28,190],"wherever":[29],"injury.":[33],"We":[34],"therefore":[35],"determined":[36],"the":[37,40,85,94,99,117,145,157,163,169,245,254,275],"effect":[38],"split":[42],"products":[43],"C3a":[44,59,67,120,130,196,236],"and":[45,62,68,81,124,131,136,140,209,230,237,249],"C5a":[46,63,69,109,132,238],"on":[47,201,258],"MSC.":[48],"FACS":[49],"analysis":[50],"indicated":[51],"human":[53],"bone":[54],"marrow\u2010derived":[55],"MSCs":[56,73,128],"express":[57],"cell\u2010surface":[58],"receptors":[60,64,102,180],"(C3aR)":[61],"(C5aR).":[65],"Both":[66],"induced":[70],"chemotaxis":[71],"in":[74,103,127,171,225,240],"a":[75,104,211],"dose":[76],"dependent":[77],"fashion.":[78,107],"Specific":[79],"C3aR":[80,164,255],"C5aR":[82,257],"inhibitors":[83],"blocked":[84],"chemotactic":[86],"response":[87,95,118],"as":[88],"did":[89],"pertussis":[90],"toxin,":[91],"indicating":[92],"was":[96,151,166,216],"mediated":[97],"by":[98],"anaphylatoxin":[101],"Gi":[105],"activation\u2010dependent":[106],"While":[108],"causes":[110],"prolonged":[111,134,205],"activation":[112,206],"many":[114],"cell":[115],"types,":[116],"generally":[122],"transient":[123],"weak.":[125],"However,":[126],"both":[129,148],"caused":[133],"ERK1/2":[135],"Akt":[137],"phosphorylation.":[138],"Phospho\u2010Akt":[139],"phospho\u2010ERK1/2":[141],"were":[142],"translocated":[143,167],"nucleus":[146,170],"with":[147,153,218],"stimuli,":[149],"which":[150,266,273],"associated":[152,217],"subsequent":[154],"phosphorylation":[155],"transcription":[158],"factor":[159],"Elk.":[160],"More":[161],"surprisingly,":[162],"itself":[165],"C3a\u2010stimulated":[172],"MSCs.":[173],"Since":[174],"nuclear":[175],"translocation":[176],"G\u2010protein":[178],"coupled":[179],"has":[181],"been":[182],"shown":[183],"induce":[185],"long\u2010term":[186],"effects":[187],"including":[188,227],"transcriptional":[189],"this":[191],"novel":[192],"observation":[193],"implies":[194],"exerts":[197],"far":[198],"reaching":[199],"consequences":[200],"MSC":[202,226,248,259],"biology.":[203],"The":[204],"C3aRs":[208],"lesser":[212],"degree":[213],"C5aRs":[215],"increased":[219],"expression":[220],"several":[222],"angiogenic":[223],"factors":[224],"VEGF,":[228],"bFGF":[229],"IL\u20108.":[231],"These":[232],"results":[233],"suggest":[234],"present":[239],"injured":[241],"tissues":[242],"contribute":[243],"recruitment":[246],"means":[251],"activating":[253],"or":[256],"could":[260],"improve":[261],"ischemic":[263],"potential,":[265],"would":[267],"be":[268],"more":[269],"attractive":[270],"for":[271],"C3a,":[272],"lacks":[274],"inflammatory":[276],"action":[277],"C5a.":[279]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}